Gianluca Pirozzi

1 ta ish

Sanofi (United States)

1. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

   Claus Bachert, Peter W. Hellings, Joaquim Mullol +14

   Boshqa20192 iqtibos

   ABIABI:AkademIndex/2026.other.633272